TherapeuticsMD Announces Fourth Quarter and Full-Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- US stock futures tick higher as tech steadies though oil, yields stay high
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
TherapeuticsMD (TXMD) Reports In-Line Q4 EPS
February 23, 2017 6:46 AM ESTTherapeuticsMD (NYSE: TXMD) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $4.49 million versus the consensus estimate of $5.91 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More